High frequency of lipoprotein risk levels for cardiovascular disease in Takayasu arteritis

Clinical Rheumatology

Volumn 28, Issue 7, 2009, Pages 801-805

  Carvalho, Jozélio Freire ^a   Bonfá, Eloísa ^a   Bezerra, Mailze C ^a   Pereira, Rosa Maria Rodrigues ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

C reactive protein; Dyslipidemia; Inflammatory markers; Lipid profile; Takayasu arteritis; Vasculitis

Indexed keywords

C REACTIVE PROTEIN; GLUCOCORTICOID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PREDNISONE; TRIACYLGLYCEROL;

ADULT; AORTA ARCH SYNDROME; ARTICLE; ATHEROGENESIS; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; DRUG USE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; PRIORITY JOURNAL; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ATHEROSCLEROSIS; BRAZIL; C-REACTIVE PROTEIN; COMORBIDITY; FEMALE; HUMANS; LIPOPROTEINS; PREMENOPAUSE; RISK FACTORS; TAKAYASU ARTERITIS;

EID: 67349169971     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1153-8     Document Type: Article

References (37)

1. Yamato M, Lecky JW, Hiramatsu K, Kohda E (1986) Takayasu arteritis: radiographic and angiographic findings in 59 patients. Radiology 161:329-334
2. Numano F (2002) Takayasu's arteritis: Clinical aspects. In: Hoffman GS, Weyand CM (eds) Inflammatory diseases of blood vessels. Marcel Dekker, New York, pp 455-466
3. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL et al (1994) Nomenclature of systemic vasculitides: Proposal of an international consensus conference. Arthritis Rheum 37:187-192
4. Ross R (1999) Atherosclerosis - an inflammatory disease. N Engl J Med 340:115-126
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2496
6. Numano F (2000) Vasa vasoritis, vasculitis and atherosclerosis. Int J Cardiol 75(Suppl 1):S1-S8
7. Numano F, Kishi Y, Tanaka A, Ohkawara M, Kakuta T, Kobayashi Y (2000) Inflammation and atherosclerosis. Atherosclerotic lesions in Takayasu arteritis. Ann NY Acad Sci 902:65-76
8. Numano F, Okawara M, Inomata H, Kobayashi Y (2000) Takayasu's arteritis. Lancet 356:1023-1025
9. Filer A, Nicholls D, Corston R, Carey P, Bacon P (2001) Takayasu arteritis and atherosclerosis: Illustrating the consequences of endothelial damage. J Rheumatol 28:2752-2753
10. Sun Y, Yip PK, Jeng JS, Hwang BS, Lin WH (1996) Ultrasonographic study and long-term follow-up of Takayasu's arteritis. Stroke 27:2178-2182
11. Sharma S, Sharma S, Taneja K, Gupta AK, Rajani M (1996) Morphologic mural changes in the aorta revealed by CT in patients with nonspecific aortoarteritis (Takayasu's arteritis). Am J Roentgenol 167:1321-1325
12. Taniguchi N, Itoh K, Honda M, Obayashi T, Nakamura M, Kawai F et al (1997) Comparative ultrasonographic and angiographic study of carotid arterial lesions in Takayasu's arteritis. Angiology 48:9-20
13. Lefebvre C, Rance A, Paul JF, Beguin C, Bletry O, Amoura Z et al (2000) The role of B-mode ultrasonography and electron beam computed tomography in evaluation of Takayasu's arteritis: A study of 43 patients. Semin Arthritis Rheum 30:25-32
14. Park SH, Chung JW, Lee JW, Han MH, Park JH (2001) Carotid artery involvement in Takayasu's arteritis: Evaluation of the activity by ultrasonography. J Ultrasound Med 20:371-378
15. Seyahi E, Ugurlu S, Cumali R, Balci H, Seyahi N, Yurdakul S, Yazici H (2006) Atherosclerosis in Takayasu arteritis. Ann Rheum Dis 65:1202-1207
16. Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM et al (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33:1129-1134
17. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, Hoffman GS (1994) Takayasu arteritis. Ann Intern Med 120:919-929
18. Bezerra MC, Calomeni GD, Caparbo VF, Gebrim ES, Rocha MS, Pereira RM (2005) Low bone density and low serum levels of soluble RANK ligand are associated with severe arterial calcification in patients with Takayasu arteritis. Rheumatol (Oxford) 44:1503-1506
19. Siedel J, Hägele EO, Zielgenhorn J, Wahlefeld AW (1983) Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 29:1075-1080
20. Fossati P, Prencipe L (1982) Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 28:2077-2080
21. Warnick GR, Cheung NC, Albers JJ (1979) Comparison of current methods for high density lipoprotein cholesterol quantification. Clin Chem 25:596-604
22. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
23. Williams CM (2004) Lipid metabolism in women. Proc Nutr Soc 63:153-160
24. Regitz-Zagrosek V, Lehmkuhl E, Mahmoodzadeh S (2007) Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease. Gend Med 4(Suppl B):S162-S177
25. Heiss G, Tamir I, Davis CE, Tyroler HA, Rifkand BM, Schonfeld G et al (1980) Lipoprotein-cholesterol distribution in selected North American populations: The lipid research clinics program prevalence study. Circulation 61:302-315
26. Kannel WB, Hjortland MC, McNamara PM, Gordon T (1976) Menopause and risk of cardiovascular disease. The Framingham Study. Ann Intern Med 85:447-452
27. Brown WV (1994) Lipoprotein disorders in diabetes mellitus. Med Clin North Am 78:143-161
28. Thompson GR, Soutar AK, Spengel FA, Jadhav A, Gavigan SJ, Myant NB (1981) Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo. Proc Natl Acad Sci USA 78:2591-2595
29. Attman PO, Alaupovic P (1991) Lipid and apolipoprotein profiles of uremic dyslipoproteinemia - relation to renal function and dialysis. Nephron 57:401-410
30. Seko Y (2007) Giant cell and Takayasu arteritis. Curr Opin Rheumatol 19:39-43
31. Nashel DJ (1986) Is atherosclerosis a complication of long-term corticosteroid treatment. Am J Med 80:925-929
32. Al Rayyes O, Wallmark A, Florén CH (1997) Additive inhibitory effect of hydrocortisone and cyclosporine on low-density lipoprotein receptor activity in cultured HepG2 cells. Hepatology 26:967-971
33. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM Jr (1998) Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. Air Force/ Texas Coronary Atherosclerosis Prevention Study. JAMA 279:1615-1622
34. Park YB, Lee SK, Lee WK, Suh CH, Lee CW, Lee CH (1999) Lipid profiles in untreated patients with rheumatoid arthritis. J Rheumatol 26:1701-1704
35. Borba EF, Bonfá E (1997) Dyslipoproteinemias in systemic lupus erythematosus: Influence of disease, activity, and anticardiolipin antibodies. Lupus 6:533-539
36. de Carvalho JF, Borba EF, Viana VS, Bueno C, Leon EP, Bonfá E (2004) Anti-lipoprotein lipase antibodies: A new player in the complex atherosclerotic process in systemic lupus erythematosus? Arthritis Rheum 50:3610-3615
37. Quéméneur T, Martin-Nizard F, Kandoussi A et al (2007) PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis. Semin Arthritis Rheum 37:149-155